OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment
Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2621-2621
Open Access | Times Cited: 14
Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2621-2621
Open Access | Times Cited: 14
Showing 14 citing articles:
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
Immune Watchdogs: Tissue-Resident Lymphocytes as Key Players in Cancer Defense
Ashiq Ali, Khadija Younas, Aisha Khatoon, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104644-104644
Closed Access
Ashiq Ali, Khadija Younas, Aisha Khatoon, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104644-104644
Closed Access
Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen
Gargi Das, J. Ptáček, Jana Nedvědová, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0307353-e0307353
Open Access
Gargi Das, J. Ptáček, Jana Nedvědová, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0307353-e0307353
Open Access
β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma
Parker Mathews, Xiaobei Wang, Jian Wu, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 496-496
Open Access
Parker Mathews, Xiaobei Wang, Jian Wu, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 496-496
Open Access
Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment
Shilpi Singh, Debashis Barik, Karl Lawrie, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14960-14960
Open Access | Times Cited: 8
Shilpi Singh, Debashis Barik, Karl Lawrie, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14960-14960
Open Access | Times Cited: 8
Gut redox and microbiome: charting the roadmap to T-cell regulation
Sujata Prasad, Shilpi Singh, Samuel Menge, et al.
Frontiers in Immunology (2024) Vol. 15
Closed Access | Times Cited: 2
Sujata Prasad, Shilpi Singh, Samuel Menge, et al.
Frontiers in Immunology (2024) Vol. 15
Closed Access | Times Cited: 2
Role of Extracellular vesicle microRNAs and RNA binding proteins on glioblastoma dynamics and therapeutics development
Shilpi Singh, Clark C. Chen, Stefan Kim, et al.
Extracellular Vesicle (2024) Vol. 4, pp. 100049-100049
Open Access | Times Cited: 2
Shilpi Singh, Clark C. Chen, Stefan Kim, et al.
Extracellular Vesicle (2024) Vol. 4, pp. 100049-100049
Open Access | Times Cited: 2
Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment
Durre Aden, Niti Sureka, Samreen Zaheer, et al.
Immunology (2024)
Open Access | Times Cited: 2
Durre Aden, Niti Sureka, Samreen Zaheer, et al.
Immunology (2024)
Open Access | Times Cited: 2
Small Molecule Inhibitors Targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for Cancer Immunotherapy (2020-2024)
Binbin Cheng, Jiaoli Lv, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117141-117141
Closed Access | Times Cited: 2
Binbin Cheng, Jiaoli Lv, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117141-117141
Closed Access | Times Cited: 2
Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment
Yeva Meshkovska, Artem Abramov, Shaheen Mahira, et al.
(2024)
Open Access | Times Cited: 1
Yeva Meshkovska, Artem Abramov, Shaheen Mahira, et al.
(2024)
Open Access | Times Cited: 1
Small molecule innate immune modulators in cancer therapy
Avijit Goswami, Sandeep Goyal, Princy Khurana, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Avijit Goswami, Sandeep Goyal, Princy Khurana, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
New Keys for the Old Locks: Utilizing Spindle Assembly Checkpoints as a Target for Cancer Therapy
Manisha Singh, Pallabi Banerjee, Risha Singh, et al.
(2024)
Closed Access
Manisha Singh, Pallabi Banerjee, Risha Singh, et al.
(2024)
Closed Access
Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen
Gargi Das, J. Ptáček, Barbora Havlínová, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Gargi Das, J. Ptáček, Barbora Havlínová, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment
Yeva Meshkovska, Artem Abramov, Shaheen Mahira, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 651-675
Open Access
Yeva Meshkovska, Artem Abramov, Shaheen Mahira, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 651-675
Open Access
